Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. MacDonald (2015)
Vaccine hesitancy: Definition, scope and determinants.Vaccine, 33 34
T. Concannon, P. Meissner, J. Grunbaum, N. Mcelwee, J. Guise, John Santa, P. Conway, Denise Daudelin, E. Morrato, L. Leslie (2012)
A New Taxonomy for Stakeholder Engagement in Patient-Centered Outcomes ResearchJournal of General Internal Medicine, 27
Low rate of in fl uenza and pneumococcal
V. Boucher, S. Peláez, C. Gemme, S. Labbé, K. Lavoie (2020)
Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature reviewClinical Rheumatology
T. Glück, U. Müller-Ladner (2008)
Vaccination in patients with chronic rheumatic or autoimmune diseases.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 46 9
Hajer Euchi, E. Chirpaz, A. Foucher, N. Sultan-Bichat, A. Randrianjohany, P. Poubeau, E. Gamon, C. Roussin, S. Osdoit, L. Raffray (2019)
Vaccination against influenza and pneumococcal infections in patients with autoimmune disorders under biological therapy: Coverage and attitudes in patients and physicians.European journal of internal medicine
S. Neusser, A. Neumann, P. Nieden, C. Speckemeier, S. Schlierenkamp, A. Walendzik, U. Karbach, I. Andreica, K. Vaupel, X. Baraliakos, U. Kiltz (2022)
Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping reviewRMD Open, 8
Perceived Usefulness and Perceived Ease of Use
W. Nowell, P. Merkel, R. McBurney, Kalen Young, S. Venkatachalam, Dianne Shaw, A. Dobes, E. Cerciello, Laura Kolaczkowski, J. Curtis, M. Kappelman (2021)
Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future DirectionsThe Patient, 14
(2021)
Vaccination against COVID19: expectations and concerns of patients with autoimmune and rheumatic diseases
I. Hmamouchi, K. Winthrop, O. Launay, M. Dougados (2015)
Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort.Vaccine, 33 12
(2020)
Frequency and predictors of influenza vaccine hesitancy in systemic autoimmune rheumatic diseases [abstract
E Sowden, WS Mitchell (2007)
An audit of influenza and pneumococcal vaccination in rheumatology outpatients, 8
Sun Lee, Juhyung Sun, Seulki Jang, S. Connelly (2022)
Misinformation of COVID-19 vaccines and vaccine hesitancyScientific Reports, 12
M. Friedman, K. Winthrop (2016)
Vaccinations for rheumatoid arthritisCurrent Opinion in Rheumatology, 28
A. Bagasra, Sara Doan, Christopher Allen (2021)
Racial differences in institutional trust and COVID-19 vaccine hesitancy and refusalBMC Public Health, 21
Taslima Akther, Tasnima Nur (2022)
A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of usePLoS ONE, 17
E. Sowden, W. Mitchell (1997)
Environmental Genome Project advances.Environmental Health Perspectives, 105
SIGNIFICANCE & INNOVATIONSThis study brought together a multistakeholder panel from the autoimmune health community to prioritize topics related to vaccine uptake for adults with autoimmune conditions by using a well‐established methodology that allows for the identification of areas of consensus and disagreement across stakeholder groups. Decision to vaccinate is a multifaceted process that is the result of a complex series of attitudes and decision‐making actions involving a range of stakeholders; therefore, multistakeholder considerations are integral to prioritize topics.Safety and efficacy of vaccines for adults living with autoimmune conditions emerged as the highest priority topic across all stakeholder groups, with concerns that range from whether certain vaccines could cause an exacerbation of autoimmune disease to the degree to which autoimmune diseases or use of immunomodulatory therapies may blunt vaccine response.Generating high‐quality vaccine safety and efficacy data in patients with autoimmune disease and ensuring effective messaging to patients living with autoimmune conditions is critical to improving vaccine uptake and improving the health of patients.INTRODUCTIONPeople living with autoimmune diseases (eg, rheumatoid arthritis or systemic lupus erythematosus) have nearly twice the risk of acquiring severe, vaccine‐preventable infections, as well as a higher risk of serious infection‐related complications, making vaccination a high priority in
ACR Open Rheumatology – Wiley
Published: Jun 1, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.